Innovative Partnership Reduces Cost Of Bayer’s Long-Acting Reversible Contraceptive Implant By More Than 50 Percent

nitiative will expand access to contraceptives for 27 million women in low-income countries LEVERKUSEN, Germany, Feb. 27, 2013 / PRNewswire / — An unprecedented group of public and private sector partners has finalized an agreement that will make Jadelle®, an effective, long-acting, reversible contraceptive implant, available to more than 27 million women in the world’s poorest countries at a more than 50 percent price reduction over the next six years.…